Cargando…

The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression

BACKGROUND: Liquid–liquid phase separation (LLPS) within the nucleus is directly linked to driving gene expression through transcriptional complexes. Histone lysine methyltransferase 2D (KMT2D) is widely present in many cancers. It is known to epigenetically stimulate the expression of genes associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weihan, Wu, Lei, Jia, Hui, Lin, Zenghua, Zhong, Renhao, Li, Yukun, Jiang, Chenwei, Liu, Shifan, Zhou, Xiaorong, Zhang, Erhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579673/
https://www.ncbi.nlm.nih.gov/pubmed/34758724
http://dx.doi.org/10.1186/s11658-021-00292-7
_version_ 1784596474353418240
author Li, Weihan
Wu, Lei
Jia, Hui
Lin, Zenghua
Zhong, Renhao
Li, Yukun
Jiang, Chenwei
Liu, Shifan
Zhou, Xiaorong
Zhang, Erhao
author_facet Li, Weihan
Wu, Lei
Jia, Hui
Lin, Zenghua
Zhong, Renhao
Li, Yukun
Jiang, Chenwei
Liu, Shifan
Zhou, Xiaorong
Zhang, Erhao
author_sort Li, Weihan
collection PubMed
description BACKGROUND: Liquid–liquid phase separation (LLPS) within the nucleus is directly linked to driving gene expression through transcriptional complexes. Histone lysine methyltransferase 2D (KMT2D) is widely present in many cancers. It is known to epigenetically stimulate the expression of genes associated with tumorigenesis and metastasis. Our analyses show that KMT2D possesses two distinct low-complexity domains (LCDs) capable of driving the assembly of membrane-less condensates. The dependence of the mechanisms underlying monomethylation of H3K4 on the LLPS microenvironment derived from KMT2D LCDs is unclear in tumor. METHODS: KMT2D LCD-depletion cells were used to investigate tumor cell proliferation, apoptosis, and migration. We identified some core proteins, including WDR5, RBBP5, and ASH2L, which are involved in the KMT2D-associated catalytic complex in KMT2D LCD-deficient cells to further elucidate the mechanism that decreases monomethylation of H3K4. We also evaluated the viability of KMT2D LCD-deficient cells in vivo. Finally, using 1,6-hexanediol (HD), an inhibitor of LLPS, we determined cell activities associated with KMT2D function in wild-type PANC-1 cells. RESULTS: Without the LLPS microenvironment in KMT2D LCD-deficient cells or wild-type PANC-1 cells treated with HD, the WDR5 protein was significantly less stable and the protein–protein interactions between the components of the KMT2D–enzyme complex were attenuated, impairing the formation of the complex. Moreover, with the decrease in H3K4me1 level at enhancers, transcription factors such as LIFR and KLF4 were markedly downregulated, effectively inhibiting tumor progression. In xenograft tumor models, PANC-1 cells lacking the KMT2D LCDs showed effectively suppressed tumor growth compared to normal cells. CONCLUSIONS: Our data indicate that the two low-complexity domains of the KMT2D protein could form a stable LLPS microenvironment, promoting the KMT2D catalysis of H3K4 monomethylation through stabilization of the WDR5 protein and KMT2D–enzyme complex. Therefore, finding ways to regulate the LLPS microenvironment will be benefitial for new cancer treatment strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11658-021-00292-7.
format Online
Article
Text
id pubmed-8579673
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85796732021-11-10 The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression Li, Weihan Wu, Lei Jia, Hui Lin, Zenghua Zhong, Renhao Li, Yukun Jiang, Chenwei Liu, Shifan Zhou, Xiaorong Zhang, Erhao Cell Mol Biol Lett Research BACKGROUND: Liquid–liquid phase separation (LLPS) within the nucleus is directly linked to driving gene expression through transcriptional complexes. Histone lysine methyltransferase 2D (KMT2D) is widely present in many cancers. It is known to epigenetically stimulate the expression of genes associated with tumorigenesis and metastasis. Our analyses show that KMT2D possesses two distinct low-complexity domains (LCDs) capable of driving the assembly of membrane-less condensates. The dependence of the mechanisms underlying monomethylation of H3K4 on the LLPS microenvironment derived from KMT2D LCDs is unclear in tumor. METHODS: KMT2D LCD-depletion cells were used to investigate tumor cell proliferation, apoptosis, and migration. We identified some core proteins, including WDR5, RBBP5, and ASH2L, which are involved in the KMT2D-associated catalytic complex in KMT2D LCD-deficient cells to further elucidate the mechanism that decreases monomethylation of H3K4. We also evaluated the viability of KMT2D LCD-deficient cells in vivo. Finally, using 1,6-hexanediol (HD), an inhibitor of LLPS, we determined cell activities associated with KMT2D function in wild-type PANC-1 cells. RESULTS: Without the LLPS microenvironment in KMT2D LCD-deficient cells or wild-type PANC-1 cells treated with HD, the WDR5 protein was significantly less stable and the protein–protein interactions between the components of the KMT2D–enzyme complex were attenuated, impairing the formation of the complex. Moreover, with the decrease in H3K4me1 level at enhancers, transcription factors such as LIFR and KLF4 were markedly downregulated, effectively inhibiting tumor progression. In xenograft tumor models, PANC-1 cells lacking the KMT2D LCDs showed effectively suppressed tumor growth compared to normal cells. CONCLUSIONS: Our data indicate that the two low-complexity domains of the KMT2D protein could form a stable LLPS microenvironment, promoting the KMT2D catalysis of H3K4 monomethylation through stabilization of the WDR5 protein and KMT2D–enzyme complex. Therefore, finding ways to regulate the LLPS microenvironment will be benefitial for new cancer treatment strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11658-021-00292-7. BioMed Central 2021-11-10 /pmc/articles/PMC8579673/ /pubmed/34758724 http://dx.doi.org/10.1186/s11658-021-00292-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Li, Weihan
Wu, Lei
Jia, Hui
Lin, Zenghua
Zhong, Renhao
Li, Yukun
Jiang, Chenwei
Liu, Shifan
Zhou, Xiaorong
Zhang, Erhao
The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression
title The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression
title_full The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression
title_fullStr The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression
title_full_unstemmed The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression
title_short The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression
title_sort low-complexity domains of the kmt2d protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579673/
https://www.ncbi.nlm.nih.gov/pubmed/34758724
http://dx.doi.org/10.1186/s11658-021-00292-7
work_keys_str_mv AT liweihan thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT wulei thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT jiahui thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT linzenghua thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT zhongrenhao thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT liyukun thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT jiangchenwei thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT liushifan thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT zhouxiaorong thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT zhangerhao thelowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT liweihan lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT wulei lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT jiahui lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT linzenghua lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT zhongrenhao lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT liyukun lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT jiangchenwei lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT liushifan lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT zhouxiaorong lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression
AT zhangerhao lowcomplexitydomainsofthekmt2dproteinregulatehistonemonomethylationtranscriptiontofacilitatepancreaticcancerprogression